Ben Ismail M, Abid F, Trabelsi S, Taktak M, Fekih M
Br Heart J. 1986 Jan;55(1):101-5. doi: 10.1136/hrt.55.1.101.
The course of 76 pregnancies is reported in 51 women who became pregnant after replacement of one or more heart valves. Age at conception ranged from 17 to 39 years (mean 25). There have been 71 deliveries and five women are still pregnant at the time of writing. In the 71 pregnancies, oral anticoagulants were given during 53, heparin during five, and no anticoagulants during 13. Fetal complications consisted of 12 spontaneous abortions (eight in pregnancies in which oral anticoagulants were given, three in which heparin was given, and one in which no anticoagulants were given), of 12 premature deliveries with seven stillbirths (three on oral anticoagulants and four without anticoagulants), and there were three neonatal deaths (in all all three instances oral anticoagulants had been given during pregnancy). The maternal complications were as follows. Two women with mitral valve prostheses on heparin had thromboembolic episodes. Four women on oral anticoagulants died and 11 developed haemorrhage or systemic embolism. Two of the deaths were caused by bacterial endocarditis, one was the result of obstruction of a mitral valve prosthesis, and one was due to haemorrhage. One patient developed pulmonary oedema during delivery which rapidly resolved. Seven patients had uterine bleeding after delivery (three of them were on heparin and one was on an antiplatelet agent).
本文报告了51名在置换一个或多个心脏瓣膜后怀孕的女性的76次妊娠过程。受孕年龄在17至39岁之间(平均25岁)。共有71例分娩,5名女性在撰写本文时仍在妊娠中。在这71次妊娠中,53次在孕期使用了口服抗凝剂,5次使用了肝素,13次未使用抗凝剂。胎儿并发症包括12例自然流产(8例发生在使用口服抗凝剂的妊娠中,3例发生在使用肝素的妊娠中,1例未使用抗凝剂的妊娠中),12例早产,其中7例死产(3例使用口服抗凝剂,4例未使用抗凝剂),还有3例新生儿死亡(所有这3例在孕期均使用了口服抗凝剂)。孕产妇并发症如下。两名使用肝素的二尖瓣置换女性发生了血栓栓塞事件。4名使用口服抗凝剂的女性死亡,11名出现出血或全身性栓塞。其中2例死亡由细菌性心内膜炎引起,1例由二尖瓣置换物阻塞导致,1例因出血所致。1例患者在分娩期间发生肺水肿,但迅速缓解。7例患者产后出现子宫出血(其中3例使用肝素,1例使用抗血小板药物)。